TGA issues quality warning and prepares to begin testing after reports of ‘questionable’ products by Steve Jones April 19, 2024April 23, 2024 Companies supplying medicinal cannabis that fails to meet TGO93 quality standards have been warned to expect […]
Industry leaders urge medical bodies to ‘lean in’ to cannabis and not allow ‘bad actors’ to tarnish the medicine’s reputation by Martin Lane April 9, 2024April 10, 2024
Cann Group eyes A$15m capital injection from New York-based investment firm by Martin Lane March 25, 2024March 27, 2024
Cann Group receives final payment from Sativite for Southern facility by Martin Lane March 22, 2024March 22, 2024
Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024February 29, 2024
No imported products tested since new GMP rules came into force, TGA admits, as MCIA calls for meeting by Steve Jones February 29, 2024February 29, 2024
Industry in the spotlight as regulators unite to explore rise in prescriptions by Steve Jones February 22, 2024February 22, 2024
AMCA and MCIA announce plans to present ‘unified voice’ to government by Martin Lane February 14, 2024February 14, 2024